Contents
Polycythemia Vera: Understanding Your Risk Factors
Published: Feb 07, 2024
Polycythemia vera (PV) is a rare blood disorder, but certain factors can increase your risk. Understanding these can help you and your doctor manage your health more effectively.
Age and Gender: The Basics
PV can occur at any age, but it's most common in people over 60. It's like many health conditions - the risk increases as you get older. Men are slightly more likely to develop PV than women, but the reason for this isn't fully understood. Think of it as a game of chance where some people have more lottery tickets than others.
Genetic Factors: The JAK2 Connection
Most people with PV have a specific genetic mutation called JAK2. This mutation isn't inherited from your parents, but rather develops during your lifetime. It's like a typo in your genetic code that leads to overproduction of blood cells. While you can't control this mutation, knowing about it can help guide treatment.
Environmental Factors: The Mystery
Some studies suggest that exposure to certain chemicals or radiation might increase the risk of PV. However, for most people with PV, no clear environmental cause is found. It's a bit like trying to solve a puzzle with missing pieces - we know some factors, but not all.
Other Blood Disorders: The Domino Effect
Having certain other blood disorders might increase your risk of developing PV. For example, people with a condition called 'idiopathic erythrocytosis' (where the body makes too many red blood cells for unknown reasons) may be at higher risk. It's like having one blood condition can sometimes open the door for another.
Frequently Asked Questions
There's no known way to prevent PV.
PV rarely runs in families, but tell your doctor if relatives have it.
Healthy habits are good, but won't prevent PV.
PV occurs in all ethnic groups, but is more common in some.
Stress doesn't cause PV, but may worsen symptoms.
Knowledge is Power
While you can't control all risk factors for PV, understanding them can help you work better with your healthcare team.
References
- Tefferi A, Barbui T. Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management. Am J Hematol. 2020;95(12):1599-1613.
- Passamonti F, Rumi E, Pungolino E, et al. Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia. Am J Med. 2004;117(10):755-761.
- Barbui T, Thiele J, Gisslinger H, et al. The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion. Blood Cancer J. 2018;8(2):15.
This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic. Always discuss health information with your healthcare provider.
AI Doctor Visit Required
Appointments available 24/7
Top licensed doctors
Available in all 50 states
Full service care
Prescriptions, referrals & treatment
No insurance needed
All notes available in Doctronic
15-min consultation. No hidden costs.
AI Doctor Visit Required
Please Chat With Our AI Doctor First
Our AI doctor assessment helps our human doctors prepare for your video visit and provide better care
For safety reasons we have been forced to end this consultation.
If you believe this is a medical emergency please call 911 or your local emergency services immediately.
If you are experiencing emotional distress, please call the the Suicide & Crisis Lifeline at 988 or your local crisis services immediately.
Contact us
You can also email us at help@doctronic.ai
We aim to reply within 5-7 days
How likely are you to recommend Doctronic to friends or family?